Latigo Biotherapeutics, Inc. (LTGO) research

Latigo Biotherapeutics, Inc.
ShareXLinkedInReddit
Sector
Healthcare
Industry
Biotechnology
Last price
$15.90
As of

Latigo Biotherapeutics, Inc. (LTGO): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-03.

As of . Source: SEC EDGAR filings for LTGO. Method and limitations.

SHARE THIS CARD

Share the LTGO intelligence card

A branded snapshot of LTGO: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion LTGO intelligence card preview
Post to X
COMPANY DOSSIER

See the full LTGO dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for LTGO on one page. Preview it with sample data, then open it live with a free account.

Preview the LTGO dossier

Active signals for LTGO

FREE, NO ACCOUNT

Every signal on LTGO, as it fires

New filings, 13F moves and cross asset signals on LTGO land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.

Recent SEC filings, LTGO

Related tickers

See more LTGO signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to LTGOand get the insider, 13F, options, and confluence read in one view.

Preview the LTGO dossier